Delivery Order SPE2DB24D2205-SPE2DB24FDVMA
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,960.30, is for the delivery of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product, with a completion date of May 20, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.23 firm fixed-price delivery order is for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $12,960.30 firm-fixed price delivery order is for the supply of 4,565,825,583 units of the drug product VYNDAQEL 20 MG CAPSULE UD 120S. The contract has an ultimate completion date of October 7, 2024 and there was no set-aside used. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
- This federal contract award, valued at $18,784.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VYNDAQEL 20 MG CAPSULE UD 120S, a specialty pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC, valued at $999,999,999, serves as a primary vehicle for AmerisourceBergen to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.24 firm fixed-price delivery order is for the drug VYNDAQEL 20 MG CAPSULE UD 120S, with a completion date of March 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.23 firm fixed-price contract is for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product. The contract has an ultimate completion date of April 29, 2025 and was awarded on April 8, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The $13,846.97 firm fixed price contract is for the supply of 120 units of the medication VYNDAQEL 20 MG CAPSULE. The contract has an ultimate completion date of June 27, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.24 firm fixed-price delivery order is for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product. The contract has a period of performance through March 31, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product, with a ceiling value of $12,960.30 and a performance period ending on May 29, 2024. The contract is a delivery order that is priced on a firm fixed price basis. It is not designated as a set-aside contract. AmerisourceBergen...
- This federal contract award, valued at $18,784.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of February 27, 2025. The award is not designated with any set-aside requirements, indicating open competition....
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDVMADelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,960.30 firm fixed-price delivery order is for the drug VYNDAQEL 20 MG CAPSULE UD 120S, with a completion date of July 5, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 6/12/24 |